Home Actualité internationale CM – Xenon Pharma shares up on positive XEN1101 data in study of focal epilepsy in middle stage
Actualité internationale

CM – Xenon Pharma shares up on positive XEN1101 data in study of focal epilepsy in middle stage

Xenon Pharmaceuticals (XENE) Up 74.3% Pre-Launch After Reporting Positive Top-Line Results From Phase 2b Clinical Trial X-TOLE, Which Evaluated Efficacy, Safety, And Tolerance ...

Keywords:

Xenon Pharmaceuticals Inc.,NASDAQ:XENE,Epilepsy,Focal epilepsy,Clinical trial,Pharmaceutical industry,Stock,Xenon Pharmaceuticals Inc., NASDAQ:XENE, Epilepsy, Focal epilepsy, Clinical trial, Pharmaceutical industry, Stock,,,,

A LIRE AUSSI ...

[quads id=1]